Quick Answer
NEOGEN CORP reported R&D Expense of $21.09 million for fiscal year 2025.
NEOGEN CORP R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $21.09M | -6.2% |
| 2024 | $22.48M | -13.7% |
| 2023 | $26.04M | +52.7% |
| 2022 | $17.05M | +4.9% |
| 2021 | $16.25M | +10.1% |
| 2020 | $14.75M | +15.2% |
| 2019 | $12.80M | +18.0% |
| 2018 | $10.86M | +4.5% |
| 2017 | $10.38M | +5.0% |
| 2016 | $9.89M | +3.3% |
| 2015 | $9.58M | +15.0% |
| 2014 | $8.33M | +7.0% |
| 2013 | $7.78M | +17.3% |
| 2012 | $6.64M | -2.8% |
| 2011 | $6.83M | +9.1% |
| 2010 | $6.26M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| November 30, 2025 | $4.56M | -10.7% | -11.0% |
| August 31, 2025 | $5.12M | -1.4% | +14.6% |
| February 28, 2025 | $4.47M | -7.8% | -12.4% |
| November 30, 2024 | $5.11M | -11.3% | -1.8% |
| August 31, 2024 | $5.20M | -22.7% | +7.1% |
| February 29, 2024 | $4.85M | -33.1% | -15.7% |
| November 30, 2023 | $5.76M | -15.9% | -14.4% |
| August 31, 2023 | $6.72M | +37.7% | -7.4% |
- NEOGEN CORP showed a decrease of -6.2% in R&D Expense compared to the prior fiscal year.
- Over the 2010–2025 period, NEOGEN CORP’s r&d expense has grown by 237.0% (from $6.26 million to $21.09 million).
- The most recent figure is from NEOGEN CORP’s fiscal year 2025 report (Form 10-K), filed with the SEC on July 30, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: